The effect of dance interventions on cognition, neuroplasticity, physical function, depression, and quality of life for older adults with mild cognitive impairment: A systematic review and meta-analysis

Wu, Vivien Xi; Chi, Yuchen; Lee, Jeong Kyu; Goh, Hongli Sam; Chen, Delphine Yu Mei; Haugan, Gørill; Chao, Felicia Fang Ting; Klainin‐Yobas, Piyanee

doi:10.1016/j.ijnurstu.2021.104025

Cited by 50 publications

(64 citation statements)

References 81 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An additional finding of note is that poor QOL was an independent risk factor for depressive, anxious, and stress symptoms. This result is consistent with previous research demonstrating that high levels of depressive and anxious symptoms correlated with reduced levels of QOL and health status in different individuals (Stark et al, 2002;Johnston et al, 2019;Phillips et al, 2020), such as concussion symptoms (Doroszkiewicz et al, 2021), Parkinson's disease (Lo Buono et al, 2021, older adults (Wu et al, 2021), and ischemic stroke (Huang et al, 2010).…”

Section: Associated Factors For Depressive Anxious and Stress Symptomssupporting

confidence: 92%

Depression, Anxiety, Stress, and Their Associations With Quality of Life in a Nationwide Sample of Psychiatrists in China During the COVID-19 Pandemic

Xia

Yang

et al. 2022

Front. Psychol.

View full text Add to dashboard Cite

ObjectivesThe COVID-19 pandemic has negatively affected wellbeing. However, the impact on the mental health status of Chinese psychiatrists and their relationship with quality of life (QOL) has not been examined.MethodsThis was a national cross-sectional survey performed between January 11 and March 15, 2021. Demographic and work-related data were collected anonymously using an online questionnaire. Common mental health symptoms and QOL were assessed using the Depression Anxiety Stress Scale-Chinese version and the World Health Organization Quality of Life Schedule-Brief, respectively.ResultsA total of 3,783 psychiatrists completed this questionnaire. The prevalence of depressive, anxious, and stress symptoms were 26.7% (95%CI = 25.3–28.1%), 24.1% (95%CI = 22.8–25.5%), and 11.6% (95%CI = 10–12%), respectively. Moreover, 11.1% of the participants endorsed both depressive and anxious symptoms, and 8% endorsed symptoms in all three domains. Binary logistic regression showed that aged 30–39 years (OR = 1.5, P = 0.03), male gender (OR = 1.2, P = 0.04), single (OR = 1.44, P = 0.01), and having a negative perception of the COVID-19 on healthcare (OR = 2.34, P <0.001) were factors associated with higher levels of depressive symptoms. Participants who were divorced and widowed (OR = 1.56, P = 0.03), worked more than 4 night shifts/month (OR = 1.33, P<0.001) and/or longer working years (OR = 1.71, P < 0.001), and had a negative perceived impact of the COVID-19 on healthcare (OR = 2.05, P < 0.001) were more inclined to experience anxious symptoms. In addition, psychiatrists with high QOL scores had lower odds of experiencing depressive, anxious, and stress symptoms (all P < 0.001). Multivariate analysis showed that the presence of each of the three types of mental health symptoms was independently associated with lower QOL (all P < 0.05). In addition, the depression × anxious × stress interaction was significantly correlated with lower QOL (P < 0.05).ConclusionApproximately one-fourth of psychiatrists in China experienced depressive and anxious symptoms during the COVID-19 pandemic, and more than one-tenth reported stress. Mental health symptoms were significant contributors to lower QOL. The psychological wellbeing of psychiatrists during the pandemic requires more attention, and interventions are needed to improve the psychological wellbeing and QOL of physicians who care for individuals with mental disorders.

show abstract

Section: Associated Factors For Depressive Anxious and Stress Symptomssupporting

confidence: 92%

Depression, Anxiety, Stress, and Their Associations With Quality of Life in a Nationwide Sample of Psychiatrists in China During the COVID-19 Pandemic

Xia

Yang

et al. 2022

Front. Psychol.

View full text Add to dashboard Cite

show abstract

“…Different interventions including ICU diary-keeping, cognitive therapy, rehabilitation, and physical and occupational therapy have facilitated symptomatic improvements. However, they have largely failed to improve overall patient long-term quality of life [ 6 – 8 ]. In 2018, the Society of Critical Care Medicine guidelines were updated to incorporate sleep disruption- and immobility-related items in order to better evaluate and monitor patient ICU experiences [ 9 ].…”

Section: Introductionmentioning

confidence: 99%

Nocturnal dexmedetomidine alleviates post–intensive care syndrome following cardiac surgery: a prospective randomized controlled clinical trial

Dong

Gao

et al. 2021

BMC Med

View full text Add to dashboard Cite

Background Dexmedetomidine is a sedative agent that may have the potential to reduce the risk of post-intensive care syndrome (PICS). This study aimed to establish whether prophylactic nocturnal dexmedetomidine safely reduces postoperative PICS incidence and to develop an easy-to-use model for predicting the risk of PICS following cardiac surgery. Methods This was a single-center, double-blind, randomized, prospective, placebo-controlled trial. Patients undergoing cardiac surgery were randomly assigned (1:1) to dexmedetomidine or placebo (normal saline) groups between January 2019 and July 2020. Dexmedetomidine or a similar volume of saline was administered, with an infusion rate up to 1.2 μg/kg/h until the RASS remained between − 1 and 0. The primary study endpoint was PICS incidence at 6 months follow-up, as defined by cognitive, physical, or psychological impairments. Results We assessed 703 individuals for eligibility, of whom 508 were enrolled. Of these, there were 251 in the dexmedetomidine group and 257 in the placebo group that received the trial agent, forming a modified intention-to-treat population. PICS incidence at 6-month follow-up was significantly decreased in the dexmedetomidine group (54/251, 21.5%) relative to the placebo group (80/257, 31.1%) (odds ratio [OR] 0.793, 95% CI 0.665–0.945; p = 0.014). Psychological impairment was significantly reduced in the dexmedetomidine group relative to the placebo group (18.7% vs. 26.8%, OR 0.806, CI 0.672–0.967, p = 0.029). However, dexmedetomidine treatment was associated with a higher rate of hypotension. A nomogram revealed that age, education, a medical history of diabetes and smoking, dexmedetomidine treatment, postoperative atrial fibrillation, and sequential organ failure assessment scores at 8 h post-surgery were independent predictors of PICS. Conclusions Prophylactic nocturnal dexmedetomidine administration significantly reduced PICS incidence by a marked reduction in psychological impairment within a 6-month follow-up period. Trial registration ChiCTR, ChiCTR1800014314. Registered 5 January 2018, http://www.chictr.org.cn/index.aspx

show abstract

“…The reason why aromatherapy showed no effect on depression may be due to the fact that people with cancer reported more severe depressive symptoms than the general population ( 56 ). Moreover, antidepressant therapy required a few months to be effective, while aromatherapy had never been used for more than 10 weeks in the included studies ( 57 ).…”

Section: Discussionmentioning

confidence: 99%

The Effects of Aromatherapy on Anxiety and Depression in People With Cancer: A Systematic Review and Meta-Analysis

Bai

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

BackgroundAnxiety and depression are highly prevalent in people with cancer. Medical therapies are usually prescribed to alleviate anxiety and depression, but they are associated with a variety of adverse effects. Recently, aromatherapy showed potential as a complementary medicine to improve psychological health and wellbeing. However, its effectiveness on relieving anxiety and depression has not been established.ObjectiveThis study explored the beneficial effects of aromatherapy on psychological symptoms such as anxiety and depression in people with cancer.MethodsWe searched international databases including PubMed, Web of Science, Cochrane Library, Embase, Medline, Ebscohost, ProQuest and Scopus from inception to 31 May 2021. The risk of bias was assessed using the Cochrane Collaboration's tool for assessing risk of bias. The systematic review and meta-analysis were performed according to the PRISMA guidelines. Quantitative analysis was performed on the studies that met our inclusion criteria, and Meta-analysis was performed on the studies with available data by RevMan software.ResultsThe quality of the literatures were assessed carefully by two researchers, a total of 17 studies were included in the systematic review and 10 articles were conducted in meta-analysis. The aromatherapy was effective in relieving anxiety (SMD = −0.49, p < 0.05) in people with cancer. Subgroup analysis suggested that most effective methods were aromatic massage (SMD = −0.70, p < 0.005), aromatherapy with lavender essential oils (SMD = −1.12, p < 0.01), short-time interventions (duration < 4weeks) (SMD = −0.87, p < 0.05) and studies in Asia (SMD = −0.83, p < 0.05). Regarding depression and psychological wellbeing, there were no difference between aromatherapy and control groups.ConclusionIn cancer patients, the aromatherapy was effective for relieving anxiety. However, there was no beneficial effect on depression and psychological wellbeing.Systematic Review RegistrationPROSPERO, identifier: CRD42021272465.

show abstract

The effect of dance interventions on cognition, neuroplasticity, physical function, depression, and quality of life for older adults with mild cognitive impairment: A systematic review and meta-analysis

Cited by 50 publications

References 81 publications

Depression, Anxiety, Stress, and Their Associations With Quality of Life in a Nationwide Sample of Psychiatrists in China During the COVID-19 Pandemic

Depression, Anxiety, Stress, and Their Associations With Quality of Life in a Nationwide Sample of Psychiatrists in China During the COVID-19 Pandemic

Nocturnal dexmedetomidine alleviates post–intensive care syndrome following cardiac surgery: a prospective randomized controlled clinical trial

The Effects of Aromatherapy on Anxiety and Depression in People With Cancer: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About